[Elsevier] 8 weeks versus 12 weeks of sofosbuvir每velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India

justgettingby Post time 7 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-24 23:38
Reward30points

journalㄩLancet

AuthorsㄩAmit Goel, DMa ∙ Sumit Rungta, DMb ∙ Vinod Kumar, DMc ∙ Shalimar, DMd ∙ Ajay Kumar, DMe ∙ Harshita Katiyar, MSc

Published dateㄩSeptember 30, 2026

DOIㄩ10.1016/S0140-6736(26)01380-2

PDF linkㄩhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01380-2

Article linkㄩhttps://doi.org/10.1016/S0140-6736(26)01380-2


RemarkㄩThanks for your help!

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Hien2114 Post time 7 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    4170


Daily Top Contributors

Return to the list